|

The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis

RECRUITINGPhase 3Sponsored by Sohag University
Actively Recruiting
PhasePhase 3
SponsorSohag University
Started2024-05-01
Est. completion2024-08-31
Eligibility
Age2 Years – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06463379

Summary

Interventional phase 3 study aiming to unravel the value of pulse steroids in achieving remission or low disease activity in refractory active JIA

Eligibility

Age: 2 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients still active despite administration o 2 DMARDs

Exclusion Criteria:

* Other connective tissue diseases
* Endocrine disorders such as Thyroid disorders.

Conditions2

ArthritisRefractory Juvenile Idiopathic Arthritis (Despite 2 DMARDs Still Active)

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.